Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Colabor Group Reports Results for the Fourth Quarter and Fiscal 2024

In This Article:

Colabor Group Inc.
Colabor Group Inc.

SAINT-BRUNO-DE-MONTARVILLE, Quebec, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) reports its results for the fourth quarter and fiscal year ended December 28, 2024.

Fourth Quarter 2024 Financial Highlights:

  • Sales increased by 3.2% to $202.6 million, compared to $196.3 million for the corresponding period of 2023;

  • Increase of net earnings from continuing operations to $0.5 million compared to $0.4 million for the corresponding period of 2023;

  • Adjusted EBITDA(1) decreased by 3.1% to $11.3 million from $11.7 million for the corresponding period of 2023 and decrease in adjusted EBITDA(1) margin to 5.6% of sales compared to 5.9% of sales during the corresponding period of 2023; and

  • Cash flow from operating activities increased to $10.6 million compared to $8.9 million for the fourth quarter of 2023.

Fiscal 2024 Financial Highlights:

  • Consolidated sales were $657.1 million, down of 0.3% compared to fiscal year 2023;

  • Net earnings from continuing operations decreased to $1.6 million compared to $6.0 million for fiscal year 2023;

  • Adjusted EBITDA(1) decreased to $35.4 million or 5.4% of sales compared to $37.6 million or 5.7% of sales for the fiscal year 2023;

  • Cash flow generated by operating activities were $37.2 million compared to $28.9 million in 2023; and

  • Net debt(2) decreased to $47.8 million, compared to $61.5 million as at December 30, 2023. The leverage ratio(3) is 2.4x as at December 28, 2024, compared to 2.7x as at December 30, 2023.

Events since the end of fiscal year 2024:

  • On February 19, 2025, the Company announced the signature of an agreement to acquire the assets related to the food distribution activities of Alimplus Inc. ("Alimplus"), operating under the name Mayrand Plus, and all of the shares of its subsidiary Tout-Prêt Inc. for an amount of $51.5 million, subject to certain adjustments. The acquisition is subject to obtaining all required regulatory approvals. It is expected that the closing will occur during the second quarter.

Table of Fourth Quarter 2024 Financial Highlights:

Financial highlights

16 weeks

52 weeks

(in thousands of dollars, except percentages, per share data and financial leverage ratio)

2024

 

2023

 

2024

 

2023

 

$

 

$

 

$

 

$

 

Sales from continuing operations

202,581

 

196,320

 

657,093

 

659,129

 

Adjusted EBITDA(1)

11,296

 

11,652

 

35,380

 

37,554

 

Adjusted EBITDA(1) margin (%)

5.6

 

5.9

 

5.4

 

5.7

 

Net earnings from continuing operations

548

 

354

 

1,615

 

6,047

 

Net earnings (loss)

560

 

(101

)

1,556

 

5,592

 

Per share - basic and diluted ($)

0.01

 

 

0.02

 

0.05

 

Cash flow from operating activities

10,551

 

8,899

 

37,178

 

28,943

 

Financial position

 

 

 

As at

 

As at

 

 

 

 

 

December 28,

 

December 30,

 

 

 

 

 

2024

 

2023

 

Net debt(2)

 

 

 

47,802

 

61,481

 

Financial leverage ratio(3)

 

 

 

2.4

x

2.7

x

(1) Non-IFRS measure. Refer to the table Reconciliation of Net Earnings to adjusted EBITDA in MD&A section 5 "Non-IFRS Performance Measures". Adjusted EBITDA corresponds to net operating earnings before costs not related to current operations, depreciation and amortization and expenses for stock-based compensation plan.
(2) Non-IFRS measure. Refer to MD&A section 5 "Non-IFRS Performance Measures". Net debt corresponds to bank indebtedness, current portion of long-term debt and long-term debt, net of cash.
(3) Financial leverage ratio is an indicator of the Company's ability to service its long-term debt. It is defined as net debt / adjusted EBITDA less lease liability payments and interests on lease obligations for the last four quarters. The corresponding figure for 2023 has been restated to reflect the new calculation method established for 2024. Refer to MD&A section 5 "Non-IFRS Performance Measures".